Literature DB >> 16902

Participation of hemoglobins A and F in polymerization of sickle hemoglobin.

M A Goldberg, M A Husson, H F Bunn.   

Abstract

Mesh：

Substances：

Year:  1977        PMID： 16902

Source DB:  PubMed          Journal:  J Biol Chem        ISSN： 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  30 in total

1.  A model for the sickle hemoglobin fiber using both mutation sites.

Authors:  A Roufberg; F A Ferrone
Journal:  Protein Sci       Date:  2000-05       Impact factor: 6.725

2.  Pair-wise interactions of polymerization inhibitory contact site mutations of hemoglobin-S.

Authors:  Sonati Srinivasulu; Krishnaveni Perumalsamy; Rajendra Upadhya; Belur N Manjula; Steven Feiring; Raouf Alami; Eric Bouhassira; Mary E Fabry; Ronald L Nagel; A Seetharama Acharya
Journal:  Protein J       Date:  2006-12       Impact factor: 2.371

3.  Correction of murine sickle cell disease using gamma-globin lentiviral vectors to mediate high-level expression of fetal hemoglobin.

Authors:  Tamara I Pestina; Phillip W Hargrove; Dennis Jay; John T Gray; Kelli M Boyd; Derek A Persons
Journal:  Mol Ther       Date:  2008-12-02       Impact factor: 11.454

Review 4.  Fetal Hemoglobin Induction by Epigenetic Drugs.

Authors:  Donald Lavelle; James Douglas Engel; Yogen Saunthararajah
Journal:  Semin Hematol       Date:  2018-04-22       Impact factor: 3.851

5.  Sparing effect of hemoglobin F and hemoglobin A2 on the polymerization of hemoglobin S at physiologic ligand saturations.

Authors:  W N Poillon; B C Kim; G P Rodgers; C T Noguchi; A N Schechter
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

Review 6.  Hb F in sickle cell anemia.

Authors:  A D Adekile; T H Huisman
Journal:  Experientia       Date:  1993-01-15

Review 7.  Treating sickle cell disease by targeting HbS polymerization.

Authors:  William A Eaton; H Franklin Bunn
Journal:  Blood       Date:  2017-04-06       Impact factor: 22.113

8.  Fetal hemoglobin silencing in humans.

Authors:  Patricia A Oneal; Nicole M Gantt; Joseph D Schwartz; Natarajan V Bhanu; Y Terry Lee; John W Moroney; Christopher H Reed; Alan N Schechter; Naomi L C Luban; Jeffery L Miller
Journal:  Blood       Date:  2006-05-30       Impact factor: 22.113

9.  Reticulocyte parameters and hemoglobin F production in sickle cell disease patients undergoing hydroxyurea therapy.

Authors:  R Borba; C S P Lima; H Z W Grotto
Journal:  J Clin Lab Anal       Date:  2003       Impact factor: 2.352

Review 10.  Butyrate-induced reactivation of the fetal globin genes: a molecular treatment for the beta-hemoglobinopathies.

Authors:  S P Perrine; D V Faller
Journal:  Experientia       Date:  1993-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.